Iterum Therapeutics Plc (ITRM)
NASDAQ:ITRM
US Market
Holding ITRM?
Track your performance easily

Iterum Therapeutics (ITRM) Financial Statements

724 Followers

Iterum Therapeutics Financial Overview

Iterum Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.997; its P/E ratio is -0.55; Iterum Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.97M$ -7.05M$ -12.06M$ -9.77M$ -5.07M
EBITDA$ -4.39M$ -6.48M$ -11.03M$ -8.75M$ -4.22M
Net Income Common Stockholders$ -5.00M$ -7.10M$ -12.24M$ -9.67M$ -5.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.72M$ 18.21M$ 44.73M$ 51.82M$ 60.80M
Total Assets$ 14.17M$ 19.63M$ 51.02M$ 58.12M$ 66.83M
Total Debt$ 12.95M$ 12.20M$ 11.67M$ 10.88M$ 10.09M
Net Debt$ 1.24M$ -6.01M$ -33.07M$ -40.95M$ -50.71M
Total Liabilities$ 25.09M$ 25.77M$ 43.89M$ 39.16M$ 38.83M
Stockholders Equity$ -10.91M$ -6.15M$ 7.13M$ 18.96M$ 28.00M
Cash Flow-
Free Cash Flow$ -6.76M$ -13.08M$ -7.65M$ -9.59M$ -4.31M
Operating Cash Flow$ -6.76M$ -13.08M$ -7.63M$ -9.59M$ -4.26M
Investing Cash Flow$ 4.20M$ 7.21M$ 4.35M$ 5.11M$ 4.38M
Financing Cash Flow$ 167.00K$ 7.22M$ 200.00K$ 235.00K$ 433.00K
Currency in USD

Iterum Therapeutics Earnings and Revenue History

Iterum Therapeutics Debt to Assets

Iterum Therapeutics Cash Flow

Iterum Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis